The X-ray structure of RANTES: Heparin-derived disaccharides allows the rational design of chemokine inhibitors

Structure

Volumn 12, Issue 11, 2004, Pages 2081-2093

  Shaw, Jeffrey P ^a   Johnson, Zoë ^a   Borlat, Frédéric ^a   Zwahlen, Catherine ^b   Kungl, Andreas ^c   Roulin, Karen ^a   Harrenga, Axel ^a   Wells, Timothy N C ^a   Proudfoot, Amanda E I ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^b Geneva Proteomics Inc   (Switzerland)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; DISACCHARIDE; GLYCOSAMINOGLYCAN; HEPARIN; OLIGOSACCHARIDE; RANTES;

ARTICLE; BINDING AFFINITY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; T LYMPHOCYTE ACTIVATION; X RAY ANALYSIS; X RAY CRYSTALLOGRAPHY;

CARBOHYDRATE SEQUENCE; CHEMOKINES; CRYSTALLOGRAPHY, X-RAY; HEPARIN; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; RANTES;

EID: 7944221827     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2004.08.014     Document Type: Article

References (39)

1. Alouani S. Scintillation proximity binding assay. Methods Mol. Biol. 138:2000;135-141
2. Baggiolini M., Dewald B., Moser B. Human chemokines. an update Annu. Rev. Immunol. 15:1997;675-705
3. Baltus T., Weber K.S., Johnson Z., Proudfoot A.E., Weber C. Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood. 102:2003;1985-1988
4. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system. A new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54:1998;905-921
5. Burns J.M., Gallo R.C., DeVico A.L., Lewis G.K. A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling. J. Exp. Med. 188:1998;1917-1927
6. Chakravarty L., Rogers L., Quach T., Breckenridge S., Kolattukudy P.E. Lysine 58 and histidine 66 at the C-terminal alpha-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J. Biol. Chem. 273:1998;29641-29647
7. Chung C.W., Cooke R.M., Proudfoot A.E., Wells T.N. The three-dimensional solution structure of RANTES. Biochemistry. 34:1995;9307-9314
8. Czaplewski L.G., McKeating J., Craven C.J., Higgins L.D., Appay V., Brown A., Dudgeon T., Howard L.A., Meyers T., Owen J., et al. Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J. Biol. Chem. 274:1999;16077-16084
9. Falsone S.F., Weichel M., Crameri R., Breitenbach M., Kungl A.J. Unfolding and double-stranded DNA binding of the cold shock protein homologue Cla h 8 from Cladosporium herbarum. J. Biol. Chem. 277:2002;16512-16516
10. Fernandez-Botran R., Gorantla V., Sun X., Ren X., Perez-Abadia G., Crespo F.A., Oliver R., Orhun H.I., Quan E.E., Maldonado C., et al. Targeting of glycosaminoglycan-cytokine interactions as a novel therapeutic approach in allotransplantation. Transplantation. 74:2002;623-629
11. Folkard S.G., Westwick J., Millar A.B. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur. Respir. J. 10:1997;2097-2104
12. Goger B., Halden Y., Rek A., Mosl R., Pye D., Gallagher J., Kungl A.J. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8. a model for chemokine regulation at inflammatory sites Biochemistry. 41:2002;1640-1646
13. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., Wells T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 36:1997;13570-13578
14. Hoover D., Shaw J.P., Gryczynski Z., Proudfoot A.E., Wells T.N. The crystal structure of Met-RANTES. Comparison with native RANTES and AOP-RANTES Protein Pept. Lett. 7:2000;200
15. Johnson Z., Kosco-Vilbois M.H., Herren S., Cirillo R., Muzio V., Zaratin P., Carbonatto M., Mack M., Smailbegovic A., Rose M., et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173:2004;5776-5785
16. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47(pt. 2):1991;110-119
17. Koopmann W., Ediriwickrema C., Krangel M.S. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta. J. Immunol. 163:1999;2120-2127
18. Koopmann W., Krangel M.S. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1alpha. J. Biol. Chem. 272:1997;10103-10109
19. Kuschert G.S., Coulin F., Power C.A., Proudfoot A.E., Hubbard R.E., Hoogewerf A.J., Wells T.N. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry. 38:1999;12959-12968
20. Laurence J.S., Blanpain C., Burgner J.W., Parmentier M., LiWang P.J. CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry. 39:2000;3401-3409
21. Martin L., Blanpain C., Garnier P., Wittamer V., Parmentier M., Vita C. Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry. 40:2001;6303-6318
22. Nichols A., Camps M., Gillieron C., Chabert C., Brunet A., Wilsbacher J., Cobb M., Pouyssegur J., Shaw J.P., Arkinstall S. Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3. J. Biol. Chem. 275:2000;24613-24621
23. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Carter C.W. Jr., Sweet R.M. Methods in Enzymology, Volume 276. Macromolecular Crystallography, Part A:1997;307-326 Academic Press, New York
24. Paavola C.D., Hemmerich S., Grunberger D., Polsky I., Bloom A., Freedman R., Mulkins M., Bhakta S., McCarley D., Wiesent L., et al. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J. Biol. Chem. 273:1998;33157-33165
25. Proudfoot, A.E., and Borlat, F. (2002). Chemokine Protocols. (Humana Press, Towota, NJ).
26. Proudfoot A.E., Fritchley S., Borlat F., Shaw J.P., Vilbois F., Zwahlen C., Trkola A., Marchant D., Clapham P.R., Wells T.N. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276:2001;10620-10626
27. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N., Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA. 100:2003;1885-1890
28. Rajarathnam K., Sykes B.D., Kay C.M., Dewald B., Geiser T., Baggiolini M., Clark-Lewis I. Neutrophil activation by monomeric interleukin-8. Science. 264:1994;90-92
29. Robinson E., Keystone E.C., Schall T.J., Gillett N., Fish E.N. Chemokine expression in rheumatoid arthritis (RA). evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells Clin. Exp. Immunol. 101:1995;398-407
30. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:2000;217-242
31. Skelton N.J., Aspiras F., Ogez J., Schall T.J. Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. Biochemistry. 34:1995;5329-5342
32. Spillmann D., Witt D., Lindahl U. Defining the interleukin-8-binding domain of heparan sulfate. J. Biol. Chem. 273:1998;15487-15493
33. Stringer S.E., Gallagher J.T. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J. Biol. Chem. 272:1997;20508-20514
34. Stringer S.E., Forster M.J., Mulloy B., Bishop C.R., Graham G.J., Gallagher J.T. Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha. Blood. 100:2002;1543-1550
35. Stura E.A., Martin L., Lortat-Jacob H., Vives R., Vita C. Heparin-aggregated RANTES can be crystallised. Acta Crystallogr. D Biol. Crystallogr. 58:2002;1670-1673
36. Sweeney E.A., Lortat-Jacob H., Priestley G.V., Nakamoto B., Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice. involvement in mobilization of stem/progenitor cells Blood. 99:2002;44-51
37. Vives R.R., Sadir R., Imberty A., Rencurosi A., Lortat-Jacob H. A Kinetics and Modeling Study of RANTES(9-68) Binding to Heparin Reveals a Mechanism of Cooperative Oligomerization. Biochemistry. 41:2002;14779-14789
38. Wagner L., Yang O.O., Garcia-Zepeda E.A., Ge Y., Kalams S.A., Walker B.D., Pasternack M.S., Luster A.D. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature. 391:1998;908-911
39. Wilken J., Hoover D., Thompson D.A., Barlow P.N., McSparron H., Picard L., Wlodawer A., Lubkowski J., Kent S.B. Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES. Chem. Biol. 6:1999;43-51